Study archive · AI simulation with synthetic data · Human validation pending

Fictional workflow context

Maya Chen is a fictional revenue operations analyst at a hypothetical midmarket EHR/PM/RCM software vendor. This is an AI study scenario, not evidence from a real participant.

• Frequency (assumed): Weekly specialty pipeline review.
• Tools (assumed): Reimbursement and CRM CSV extracts, a spreadsheet or local calculation tool, and a short sales operations memo.
• Usual steps (assumed): Confirm source periods and definitions; reconcile specialty mappings and counts; calculate exposure and concentration; distinguish reimbursement signals from account evidence; identify validation gaps; prepare a concise recommendation with a named reviewer and next check.
• Expected handoff: Send a decision brief to Jordan Ellis, regional sales director, with the scope and limitations of the exposure estimate, a proposed reviewer, and a concrete validation step before planning use.
• Pain points (hypotheses): Specialty mapping differences, stale extracts, unclear denominators, missing account-level evidence, and reimbursement changes that can be mistaken for buyer need.
• Decision supported: Whether a specialty exposure signal merits further account validation and limited planning review.
• Requires real-user confirmation: Actual review cadence, tools, steps, ownership, acceptable thresholds, current sales process, data quality, usefulness of the memo, and time or effort required. No historical duration or personal experience is asserted.